trimetazidine has been researched along with aluminum phosphide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobos, MA; Dueñas, A; Herreros, V; Pérez-Castrillon, JL | 1 |
| Abd El-Kareem, DM; Almaz, D; El Shehaby, DM; Elsherif, R; Sayed, SA | 1 |
2 other study(ies) available for trimetazidine and aluminum phosphide
| Article | Year |
|---|---|
Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug.
Topics: Administration, Inhalation; Adult; Aluminum Compounds; Electrocardiography; Emergencies; Humans; Male; Occupational Diseases; Phosphines; Poisoning; Tachycardia, Ventricular; Trimetazidine; Vasodilator Agents | 1999 |
Trimetazedine with hyperinsulinimea-euoglycemia, N-acetyl cysteine, and vitamin C: A new approach concept for management of aluminum phosphide poisoning.
Topics: Acetylcysteine; Aluminum Compounds; Animals; Ascorbic Acid; Hyperinsulinism; Male; Phosphines; Rabbits; Trimetazidine | 2022 |